Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas
Autor: | Burrows, Natalie, Williams, Joseph, Telfer, Brian A, Resch, Julia, Valentine, Helen R, Fitzmaurice, Richard J, Eustace, Amanda, Irlam, Joely, Rowling, Emily J, Hoang-Vu, Cuong, West, Catharine M, Brabant, Georg, Williams, Kaye J |
---|---|
Přispěvatelé: | Burrows, Natalie [0000-0001-6591-5971], Apollo - University of Cambridge Repository |
Rok vydání: | 2016 |
Předmět: |
Indazoles
Mice Nude Cell Cycle Proteins PI3K Radiation Tolerance Histones Mice Phosphatidylinositol 3-Kinases Cell Line Tumor Animals Humans Thyroid Neoplasms Hypoxia Sulfonamides Manchester Cancer Research Centre ResearchInstitutes_Networks_Beacons/mcrc Carcinoma Cell Cycle Dose-Response Relationship Radiation Carcinoma Papillary radioresistance DNA-Binding Proteins Enzyme Activation Oxygen ATR Thyroid Cancer Papillary ATM Female DNA-PKcs Neoplasm Transplantation Research Paper DNA Damage Signal Transduction |
Zdroj: | Oncotarget Burrows, N, Williams, J, Telfer, B, Resch, J, Valentine, H, Fitzmaurice, R, Eustace, A, Irlam, J, Rowling, E, Hoang-Vu, C, West, C, Brabant, G & Williams, K 2016, ' Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas ', Oncotarget, vol. 7, no. 39, pp. 63106-63123 . https://doi.org/10.18632/oncotarget.11056 |
Popis: | Anaplastic (ATC) and certain follicular thyroid-carcinomas (FTCs) are radioresistant. The Phosphatidylinositide 3-kinase (PI3K) pathway is commonly hyperactivated in thyroid-carcinomas. PI3K can modify the PI3K-related kinases (PIKKs) in response to radiation: How PIKKs interact with PI3K and contribute to radioresistance in thyroid-carcinomas is unknown. Further uncertainties exist in how these interactions function under the radioresistant hypoxic microenvironment.Under normoxia/anoxia, ATC (8505c) and FTC (FTC-133) cells were irradiated, with PI3K-inhibition (via GDC-0941 and PTEN-reconstitution into PTEN-null FTC-133s) and effects on PIKK-activation, DNA-damage, clonogenic-survival and cell cycle, assessed. FTC-xenografts were treated with 5 × 2 Gy, ± 50 mg/kg GDC-0941 (twice-daily; orally) for 14 days and PIKK-activation and tumour-growth assessed. PIKK-expression was additionally assessed in 12 human papillary thyroid-carcinomas, 13 FTCs and 12 ATCs.GDC-0941 inhibited radiation-induced activation of Ataxia-telangiectasia mutated (ATM), ATM-and Rad3-related (ATR) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs). Inhibition of ATM and DNA-PKcs was PI3K-dependent, since activation was reduced in PTEN-reconstituted FTC-133s. Inhibition of PIKK-activation was greater under anoxia: Consequently, whilst DNA-damage was increased and prolonged under both normoxia and anoxia, PI3K-inhibition only reduced clonogenic-survival under anoxia. GDC-0941 abrogated radiation-induced cell cycle arrest, an effect most likely linked to the marked inhibition of ATR-activation. Importantly, GDC-0941 inhibited radiation-induced PIKK-activation in FTC-xenografts leading to a significant increase in time taken for tumours to triple in size: 26.5 ± 5 days (radiation-alone) versus 31.5 ± 5 days (dual-treatment). PIKKs were highly expressed across human thyroid-carcinoma classifications, with ATM scoring consistently lower. Interestingly, some loss of ATM and DNA-PKcs was observed. These data provide new insight into the mechanisms of hypoxia-associated radioresistance in thyro{id-carcinoma. |
Databáze: | OpenAIRE |
Externí odkaz: |